Safety concerns related to GH treatment and CP recurrence or regrowth come from in vitro studies that have demonstrated the growth of CP cells cultured in the presence of exogenous GH [91], from the identification of GH receptors on CP cells [90], and from the observation that increased GH receptors expression may indicate higher tumor aggressiveness [160]. Here, GH1 is linked to neoplasm.